共 255 条
[1]
Davis SM(2013)Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects Vaccine 32 133-145
[2]
Deloria-Knoll M(2003)Epidemiology, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae associated with invasive pneumococcal disease in British Columbia- a call to strengthen public health pneumococcal immunization programs Can J Infec Dis Med Microbiol 14 261-266
[3]
Kassa HT(2013)Risk of invasive pneumococcal disease in children and adults with asthma: a systematic review Vaccine 31 4820-4826
[4]
O’Brien KL(2009)Asthma: epidemiology, etiology and risk factors Can Med Assoc J 181 E181-E190
[5]
Bigham M(2010)Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23) MMWR Recomm Rep 59 1102-1106
[6]
Patrick DM(2011)Vaccination of adults with asthma and COPD Allergy 66 25-31
[7]
Bryce E(2008)Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study Vaccine 26 1955-1962
[8]
Champagne S(2014)How many individuals with asthma need to be vaccinated to prevent one case of invasive pneumococcal disease? Can J Infect Dis Med Microbiol 25 147-150
[9]
Shaw C(2007)Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma J Gen Intern Med 22 62-67
[10]
Wu W(1995)Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection Vaccine 13 1533-1538